CDKN2A and hepatocellular carcinoma: Most importantly, RNA-Seq also validated the upregulation of the three genes identified in both “HBV- and HCV-HCC-specific” signatures (CDKN2A, IGF2BP3 and ZNF623) (Fig. 5A).